Related Experiment Videos

Age-related changes of serum progastrin-releasing peptide levels during childhood

N Adachi1, K Aoyagi, M Saito

  • 1Department of Pediatrics, Kumamoto University School of Medicine, Japan.

Acta Paediatrica Japonica : Overseas Edition
|June 1, 1997
PubMed

Insights

Serum ProGRP(31-98) levels are highest in newborns and decrease significantly by age five, indicating Gastrin-releasing peptide (GRP) is a crucial growth factor in early human development.

Area of Science:

  • Pediatric Endocrinology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastrin-releasing peptide (GRP) is recognized as a significant tissue-specific growth factor.
  • Understanding GRP's role in pediatric development is crucial.

Purpose of the Study:

  • To investigate the physiological significance of GRP in growing children.
  • To assess the time course of serum ProGRP(31-98) levels in children.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure serum ProGRP(31-98).
  • 118 serum samples, including cord blood, were analyzed.
  • Informed consent was obtained for all samples.

Main Results:

  • Serum ProGRP(31-98) levels were highest in cord blood and neonatal samples.
  • Levels rapidly declined by 1 year of age.
  • Levels gradually decreased to adult levels by 5 years of age.

Conclusions:

  • The time-dependent changes in serum ProGRP(31-98) suggest GRP's importance as a physiological growth factor.
  • GRP plays a vital role in fetal and neonatal tissue growth.
  • This study highlights GRP's significance in early human development.

Related Concept Videos